Leading Croatian pharmaceutical producer Pliva -- which was recently acquired by US-based Barr Pharmaceutical -- reported a 12% decrease in its overall revenues from January-September.
Principalul producător croat de produse farmaceutice Pliva -- recent achiziţionat de Barr Pharmaceutical din SUA -- a anunţat o scădere cu 12% a veniturilor totale în perioada ianuarie-septembrie.